Beginning in mid-February 2008, the 1997-2007 online version of the Science WatchŽ newsletter, ESI-Topics.com, and in-cites.com, will all be featured together on the redesigned ScienceWatch.com. All previous content from the three sites will be permanently archived, and remain accessible from any existing bookmarks to the archived pages. No new content will be added to this site. Updates and new content (updated biweekly) are available at ScienceWatch.com now.
Thomson
Essential Science Indicators - Special Topics  RSS feeds for the editorial Web sites of Essential Science Indicators.
All Topics Menu
Help || About || Contact

  
|  Previous Page  |
  |  Special Topics Menu  |  |  Next Page  |
  

ESI Special Topic of:
Attention Deficit Hyperactivity Disorder, Published July 2005

•> Search Special Topics
Attention Deficit Hyperactivity Disorder Menu

Attention Deficit Hyperactivity Disorder

An INTERVIEW with Dr. Joseph Biederman

ESI Special Topics, July 2005
Citing URL - http://www.esi-topics.com/add/interviews/JosephBiederman.html

According to our Special Topics analysis of ADD/ADHD research over the past decade, the scientist with the most-cited research is Dr. Joseph Biederman, with 294 papers cited a total of 6,866 times to date. Dr. Biederman is a contributing author to five papers in this Topic’s list of most-cited papers from the past decade and the past two years. In the ISI Essential Science Indicators Web product, Dr. Biederman’s work can be found in the field of Psychiatry/Psychology. Dr. Biederman is a Professor of Psychiatry at Harvard Medical School and Chief of the Clinical and Research Program in Pediatric Psychopharmacology at Massachusetts General Hospital in Boston. In the interview below, he talks about his highly cited work.

Joseph Biederman is also featured in ISIHighlyCited.com.

ST:  Why would you say your work is highly cited?


“[My work] deals with scientifically and clinically relevant topics and systemically addresses a void in the knowledge on ADHD and related disorders.”

Because it deals with scientifically and clinically relevant topics and systematically addresses a void in the knowledge on ADHD and related disorders.

ST:  What are the circumstances which led you to your work?

The care of patients affected with this disorder and their families and the need to understand the condition and how to best treat it.

ST:  How would you describe the significance of this work for your field?

My work helped redefine the way that ADHD is conceptualized all over the world today as a highly morbid brain disorder affecting males and females equally, of likely genetic etiology, and with associated severe risk for psychiatric and cognitive comorbidity.

ST:  How much has this research advanced since you first started publishing on it?

Dramatically! Our work has helped to support the notion accepted today that ADHD is a treatable, serious brain disorder of genetic etiology associated with high levels of psychiatric and cognitive comorbidity.

ST:  Where do you see this research going 10 years from now?

We are expanding our work to include not only careful longitudinal follow-ups of boys and girls with and without ADHD into adult years but also adding all forms of neuroimaging (PET, Spectroscopy, morphometric and functional MRI), genetic studies (including pharmacogenetic studies), and neuropsychological studies aimed at better defining and treating executive function deficits. Our work is also expanding to the study of early temperamental antecedents to ADHD in young preschool offspring of parents with this disorder, intervention studies to include pharmacological and psychotherapeutic modalities, as well as early intervention strategies for children at risk for complicated course including addictions to tobacco, alcohol, and drugs. Finally, our program will have an increasingly greater focus in adult ADHD from all of the above described perspectives.End

Joseph Biederman, M.D.
Massachusetts General Hospital
and
Harvard Medical School
Boston, MA, USA


In the ISI Essential Science Indicators Web product, Dr. Biederman is consistently among the Most-Cited Researchers in Psychiatry/Psychology.

ESI Special Topics, July 2005
Citing URL - http://www.esi-topics.com/add/interviews/JosephBiederman.html

ESI Special Topic of:
Attention Deficit Hyperactivity Disorder, Published July 2005

•> Search Special Topics
Attention Deficit Hyperactivity Disorder Menu || All Topics Menu ||
Interview Index
Help || About || Contact

ScienceWatch.com - Tracking Trends and Perfomance in Basic Research
Go to the new ScienceWatch.com

Write to the Webmaster with questions/comments. Terms of Usage.
The Research Services Group of Thomson Scientific | Send this page
(c) 2008 The Thomson Corporation.